InfuSystem Implements Leading-Edge Electronic Medical Record Data Integration System at Florida-Based Oncology Practice
January 21, 2014 - Madison Heights, MI
MADISON HEIGHTS, MI--(Marketwired - January 21, 2014) - InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or the "Company"), a leading national provider of infusion pumps and related services for the healthcare industry in the United States, today announced it has successfully implemented a complete data integration project with Advanced Medical Specialties (AMS), a foremost Oncology practice in Miami, FL, that eliminates administrative overhead and is already delivering significant time savings for the staff at AMS.
"The new system creates value for both the practice and our patients," said Cathy Maxwell, RN, OCN
Manual processes for gathering patient data, capturing physician's orders and tracking the use of pumps are now fully automated. Necessary and appropriate patient demographic, insurance, diagnostic and clinical data used to order and track the usage of ambulatory infusion provided by InfuSystem now flows automatically and directly from AMS, using Varian's ARIA® electronic medical records system, to InfuSystem.
Eric Steen, Chief Executive Officer of InfuSystem, noted that electronic connectivity with customers is a key element of the InfuSystem growth strategy. "We are thrilled to see our efforts drive the kinds of efficiencies we anticipated with AMS. We have built a scalable, rapid-deployment model and we are committed to driving this type of cutting edge integration to the entire oncology community. We look forward to rolling out implementations with additional customers on EMR platforms in 2014."
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. The Company's stock is traded on the NYSE MKT under the symbol INFU.
Certain statements contained in this release are forward-looking statements and are based on future expectations, plans and prospects for InfuSystem Holdings, Inc.'s ("InfuSystem," "INFU," "the Company," "We") business and operations that involve a number of risks and uncertainties. The Company's outlook for 2013 and other forward-looking statements in this release are made as of January 13, 2014, and the Company disclaims any duty to supplement, update or revise such statements on a going-forward basis, whether as a result of subsequent developments, changed expectations or otherwise. In connection with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, the Company is identifying certain factors that could cause actual results to differ, perhaps materially, from those indicated by these forward-looking statements. Those factors, risks and uncertainties include, but are not limited to, potential changes in overall healthcare reimbursement -- including CMS competitive bidding, sequestration, concentration of customers, increased focus on early detection of cancer, competitive treatments, dependency on Medicare Supplier Number, availability of chemotherapy drugs, global financial conditions, changes and enforcement of state and federal laws, natural forces, competition, dependency on suppliers, risks in acquisitions & joint ventures, US Healthcare Reform, relationships with healthcare professionals and organizations, technological changes related to infusion therapy, dependency on websites and intellectual property, the ability of the Company to successfully integrate acquired businesses, dependency on key personnel, dependency on banking relations and covenants, and other risks associated with our common stock, as well as any other litigation to which the Company may be subject from time to time; and other risk factors as discussed in the Company's annual report on Form 10-K for the year ended December 31, 2012 and in other filings made by the Company from time to time with the Securities and Exchange Commission.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
Rob Swadosh / Patrick Malone
The Dilenschneider Group
InfuSystem Holdings, Inc.
31700 Research Park Drive
Madison Heights, MI 48071